Atlas Trials

Evaluation of Optical Genome Mapping in Phi Negative Myeloproliferative Neoplasia in the Detection of Acquired Cytogenetic Abnormalities

Clinical trial NCT05714592 · RECRUITING

Trial details

NCT number
NCT05714592
Sponsor
Centre Hospitalier Universitaire, Amiens
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Myeloproliferative NeoplasmOptical Genome MappingCytogeneticsClonalityPrognostic Stratification
Start date
2023-05-17
Primary completion
2027-05-18
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.